Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global VB Market Portraiture
2.2. Global VB Market, by Product, 2017 (US$ Mn)
2.3. Global VB Market, by Type, 2017 (US$ Mn)
2.4. Global VB Market, by Geography, 2017 (US$ Mn)
Chapter 3. Veterinary Biologics (VB) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global VB Market, by Key Players, 2017
Chapter 4. Global Veterinary Biologics (VB) Market, by Product
4.1. Overview
4.2. Vaccines
4.3. Diagnostic Kits
4.4. Nutritional and Hormonal Supplement
4.5. Allergenic Extract
4.6. Others
Chapter 5. Global Veterinary Biologics (VB) Market, by Type
5.1. Overview
5.2. Production Animal
5.3. Companion Animal
Chapter 6. Global Veterinary Biologics (VB) Market, by Geography
6.1. Overview
6.2. North America VB Market Analysis, 2016 – 2026
6.2.1. North America VB Market, by Product, 2016 – 2026 (US$ Mn)
6.2.2. North America VB Market, by Type, 2016 – 2026 (US$ Mn)
6.2.3. North America VB Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe VB Market Analysis, 2016 – 2026
6.3.1. Europe VB Market, by Product, 2016 – 2026 (US$ Mn)
6.3.2. Europe VB Market, by Type, 2016 – 2026 (US$ Mn)
6.3.3. Europe VB Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific VB Market Analysis, 2016 – 2026
6.4.1. Asia Pacific VB Market, by Product, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific VB Market, by Type, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific VB Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America VB Market Analysis, 2016 – 2026
6.5.1. Latin America VB Market, by Product, 2016 – 2026 (US$ Mn)
6.5.2. Latin America VB Market, by Type, 2016 – 2026 (US$ Mn)
6.5.3. Latin America VB Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa VB Market Analysis, 2016 – 2026
6.6.1. MEA VB Market, by Product, 2016 – 2026 (US$ Mn)
6.6.2. MEA VB Market, by Type, 2016 – 2026 (US$ Mn)
6.6.3. MEA VB Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA
Chapter 7. Company Profiles
7.1. Boehringer Ingelheim Animal Health GmbH
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Ceva Sante Animale
7.3. Evonik Industries AG
7.4. Heska Corporation
7.5. Intetvet, Inc.
7.6. INDICAL Bioscience
7.7. IDEXX Laboratories, Inc.
7.8. Virbac, Inc.
7.9. VCA, Inc.
7.10. Zoetis
List of Figures
FIG. 1 Veterinary Biologics (VB) Market: Research Methodology
FIG. 2 VB Market Segmentation
FIG. 3 Global VB Market, by Product, 2017 (US$ Mn)
FIG. 4 Global VB Market, by Type, 2017 (US$ Mn)
FIG. 5 Global VB Market, by Geography, 2017 (US$ Mn)
FIG. 6 Attractive Investment Proposition: by Geography, 2017
FIG. 7 Competitive Analysis: Global VB Market, by Key Players, 2017
FIG. 8 Global Vaccines Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 9 Global Diagnostic Kits Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 10 Global Nutritional and Hormonal Supplements Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 11 Global Allergenic Extracts Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 12 Global Other Products Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 13 Global Production Animals Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 14 Global Companion Animals Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 15 U.S. VB Market, 2016 – 2026 (US$ Mn)
FIG. 16 Canada VB Market, 2016 – 2026 (US$ Mn)
FIG. 17 U.K. VB Market, 2016 – 2026 (US$ Mn)
FIG. 18 Germany VB Market, 2016 – 2026 (US$ Mn)
FIG. 19 Rest of Europe VB Market, 2016 – 2026 (US$ Mn)
FIG. 20 China VB Market, 2016 – 2026 (US$ Mn)
FIG. 21 Japan VB Market, 2016 – 2026 (US$ Mn)
FIG. 22 Rest of Asia Pacific VB Market, 2016 – 2026 (US$ Mn)
FIG. 23 Brazil VB Market, 2016 – 2026 (US$ Mn)
FIG. 24 Mexico VB Market, 2016 – 2026 (US$ Mn)
FIG. 25 Rest of Latin America VB Market, 2016 – 2026 (US$ Mn)
FIG. 26 GCC VB Market, 2016 – 2026 (US$ Mn)
FIG. 27 Rest of MEA VB Market, 2016 – 2026 (US$ Mn)
List of Tables
TABLE 1 Global Veterinary Biologics (VB) Market Portraiture
TABLE 2 Global VB Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 3 Global VB Market , by Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global VB Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America VB Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 6 North America VB Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 7 North America VB Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe VB Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 9 Europe VB Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 10 Europe VB Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific VB Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific VB Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific VB Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America VB Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America VB Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America VB Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East and Africa VB Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East and Africa VB Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East and Africa VB Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 20 Boehringer Ingelheim Animal Health GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Ceva Sante Animale: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Evonik Industries AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Heska Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Intervet, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 INDICAL Bioscience.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 IDEXX Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Virbac, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 VCA, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Zoetis: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)